STRATA Skin Net Income Over Time
| SSKN Stock | USD 0.35 0.04 10.26% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out STRATA Skin Performance and STRATA Skin Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could STRATA diversify its offerings? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STRATA Skin data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.63) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets | Return On Equity |
Investors evaluate STRATA Skin Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating STRATA Skin's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause STRATA Skin's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, STRATA Skin's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare STRATA Skin Sciences and related stocks such as Heart Test Laboratories, PAVmed Inc, and Biomerica Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSCS | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (2.5 M) | (4.8 M) | (6.4 M) | (6.6 M) | (8.8 M) | (7.9 M) | (8.3 M) |
| PAVM | (548.8 K) | (548.8 K) | (548.8 K) | (548.8 K) | (548.8 K) | (1.8 M) | (5.7 M) | (9.5 M) | (18 M) | (15.9 M) | (34.3 M) | (50.3 M) | (89 M) | (64.2 M) | 39.8 M | 35.8 M | 37.6 M |
| BMRA | (1.9 M) | 548.4 K | 537 K | (215.7 K) | (331.4 K) | (1.5 M) | (908.6 K) | (1.5 M) | (2.4 M) | (2.3 M) | (7.4 M) | (4.5 M) | (7.1 M) | (6 M) | (5 M) | (4.5 M) | (4.3 M) |
| NRSN | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (2.8 M) | (4 M) | (12.3 M) | (10.1 M) | (10.2 M) | (9.2 M) | (9.6 M) |
| MHUA | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.4 M | 19 M | 20 M | 6.2 M | 11.6 M | 10.8 M | 9.8 M | 11.3 M |
| IINN | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (4.6 M) | (7.2 M) | (17 M) | (4 M) | (11.3 M) | (11.1 K) | (9.9 K) | (10.4 K) |
| BCLI | (25.6 K) | (3.9 M) | (3.4 M) | (4.9 M) | (9.2 M) | (8.5 M) | (5 M) | (5 M) | (13.9 M) | (23.3 M) | (31.8 M) | (24.5 M) | (23.7 M) | (17.2 M) | 11.6 M | 10.5 M | 11 M |
| ADIL | (818 K) | (818 K) | (818 K) | (818 K) | (818 K) | (818 K) | (420.2 K) | (1.1 M) | (11.6 M) | (8.6 M) | (10.9 M) | (19.4 M) | (12.7 M) | (7 M) | (13.2 M) | (11.9 M) | (12.5 M) |
| ADXN | (20.5 M) | (31.1 M) | (26.6 M) | (14.5 M) | (1.8 M) | (4.2 M) | (3.1 M) | (3.3 M) | (1.6 M) | (14.8 M) | (12.9 M) | (15.4 M) | (20.8 M) | (10.6 M) | 7.1 M | 8.1 M | 8.5 M |
STRATA Skin Sciences and related stocks such as Heart Test Laboratories, PAVmed Inc, and Biomerica Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in STRATA Skin Sciences financial statement analysis. It represents the amount of money remaining after all of STRATA Skin Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| STRATA Skin Sciences | SSKN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 5 Walnut Grove |
| Exchange | NASDAQ Exchange |
USD 0.35
Check out STRATA Skin Performance and STRATA Skin Correlation. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
STRATA Skin technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.